{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:56:55Z","timestamp":1793336215255,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.1001\/jamaneurol.2021.3356","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T19:47:56Z","timestamp":1632772076000},"page":"1324","source":"Crossref","is-referenced-by-count":124,"title":["Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease"],"prefix":"10.1001","volume":"78","author":[{"given":"Jacobo","family":"Mintzer","sequence":"first","affiliation":[{"name":"Ralph H. Johnson VA Medical Center, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta W.","family":"Scherer","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"van Dyck","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad R.","family":"Padala","sequence":"additional","affiliation":[{"name":"Central Arkansas Veterans Healthcare System, University of Arkansas for Medical Sciences, Little Rock"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Brawman-Mintzer","sequence":"additional","affiliation":[{"name":"Ralph H. Johnson VA Medical Center, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton P.","family":"Porsteinsson","sequence":"additional","affiliation":[{"name":"University of Rochester School of Medicine and Dentistry, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Lerner","sequence":"additional","affiliation":[{"name":"University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[{"name":"Wake Forest University, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[{"name":"Emory Goizueta Alzheimer\u2019s Disease Research Center, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Burke","sequence":"additional","affiliation":[{"name":"Banner Alzheimer\u2019s Institute, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Perin","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shade","sequence":"additional","affiliation":[{"name":"Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ADMET 2 Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Kominek","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Michalak","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gessica","family":"Ni","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Good","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mecca","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Salem\u2010Spencer","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Keltz","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Morales","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily D.","family":"Clark","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Williams","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Kindy","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Freeman","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimra","family":"Jamil","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Schultz","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Sami","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana P.","family":"Padala","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Parkes","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lah","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"Vaughn","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Hales","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rapoport","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gallagher","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Li","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Black","family":"Sandra","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Vieira","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myuri","family":"Ruthirakuhan","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Babani","sequence":"additional","affiliation":[{"name":"for the ADMET 2 Research Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"noi210061r1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1017\/S1041610209991335","article-title":"Do people become more apathetic as they grow older? a longitudinal study in healthy individuals.","volume":"22","author":"Brodaty","year":"2010","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"noi210061r2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3233\/JAD-2012-112003","article-title":"Apathy and depression in mild Alzheimer\u2019s disease: a cross-sectional study using diagnostic criteria.","volume":"31","author":"Benoit","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"24 suppl","key":"noi210061r3","first-page":"S14","article-title":"[Depression and apathy in Alzheimer's disease].","volume":"32","author":"Benoit","year":"2003","journal-title":"Presse Med"},{"key":"noi210061r4","article-title":"Diagnostic criteria for apathy in neurocognitive disorders.","author":"Miller","journal-title":"Alzheimers Dement"},{"issue":"2","key":"noi210061r5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/(ISSN)1099-1166","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study.","volume":"23","author":"Steinberg","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"noi210061r6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3233\/JAD-142337","article-title":"Risk factors of caregiver burden among patients with Alzheimer\u2019s disease or related disorders: a cross-sectional study.","volume":"44","author":"Dauphinot","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"noi210061r8","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1111\/jgs.15007","article-title":"Apathy: risk factor for mortality in nursing home patients.","volume":"65","author":"Nijsten","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"noi210061r9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3233\/JAD-2012-120913","article-title":"Apathy syndrome in Alzheimer\u2019s disease epidemiology: prevalence, incidence, persistence, and risk and mortality factors.","volume":"33","author":"Vilalta-Franch","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"noi210061r10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/JAD-150391","article-title":"Longitudinal neuropsychiatric predictors of death in Alzheimer\u2019s disease.","volume":"48","author":"Spalletta","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"noi210061r11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/JCP.0b013e318172b479","article-title":"Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.","volume":"28","author":"Herrmann","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"noi210061r12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients.","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci Lett"},{"issue":"3","key":"noi210061r13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","article-title":"The mysterious motivational functions of mesolimbic dopamine.","volume":"76","author":"Salamone","year":"2012","journal-title":"Neuron"},{"issue":"5","key":"noi210061r14","article-title":"Pharmacological interventions for apathy in Alzheimer\u2019s disease.","volume":"5","author":"Ruthirakuhan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"noi210061r15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jagp.2020.04.026","article-title":"Neurobiologic rationale for treatment of apathy in Alzheimer's disease with methylphenidate.","volume":"29","author":"van Dyck","year":"2021","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"noi210061r16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005041.pub2","article-title":"Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.","author":"Epstein","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"noi210061r17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jagp.2012.12.018","article-title":"Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).","volume":"21","author":"Drye","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"issue":"8","key":"noi210061r18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.4088\/JCP.12m08099","article-title":"Safety and efficacy of methylphenidate for apathy in Alzheimer\u2019s disease: a randomized, placebo-controlled trial.","volume":"74","author":"Rosenberg","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"noi210061r19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1176\/appi.ajp.2017.17030316","article-title":"Methylphenidate for apathy in community-dwelling older veterans with mild Alzheimer\u2019s disease: a double-blind, randomized, placebo-controlled trial.","volume":"175","author":"Padala","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"1","key":"noi210061r20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13063-017-2406-5","article-title":"The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.","volume":"19","author":"Scherer","year":"2018","journal-title":"Trials"},{"issue":"20","key":"noi210061r21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"noi210061r22","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"noi210061r23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"5","key":"noi210061r24","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","article-title":"The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"noi210061r25","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer\u2019s Disease Cooperative Study-Clinical Global Impression of Change: the Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"noi210061r26","first-page":"176","article-title":"An informant-based assessment of apathy in Alzheimer disease.","volume":"15","author":"Strauss","year":"2002","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"2","key":"noi210061r29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1037\/1040-3590.13.2.230","article-title":"The Trail Making Test: a study in focal lesion patients.","volume":"13","author":"Stuss","year":"2001","journal-title":"Psychol Assess"},{"issue":"13","key":"noi210061r30","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0028-3932(99)00066-4","article-title":"Action (verb naming) fluency as an executive function measure: convergent and divergent evidence of validity.","volume":"37","author":"Piatt","year":"1999","journal-title":"Neuropsychologia"},{"issue":"4","key":"noi210061r31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/ageing\/1.4.222","article-title":"The set test: a rapid test of mental function in old people.","volume":"1","author":"Isaacs","year":"1972","journal-title":"Age Ageing"},{"issue":"3","key":"noi210061r32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/13854049508400484","article-title":"Empirical comparison of alternate forms of the Boston Naming Test.","volume":"9","author":"Franzen","year":"1995","journal-title":"Clinical Neuropsychol"},{"key":"noi210061r33","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease: the Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"noi210061r34","doi-asserted-by":"publisher","first-page":"M216","DOI":"10.1093\/geronj\/49.5.M216","article-title":"Assessing patient dependence in Alzheimer\u2019s disease.","volume":"49","author":"Stern","year":"1994","journal-title":"J Gerontol"},{"issue":"4","key":"noi210061r35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2165\/00019053-199813040-00005","article-title":"Valuation of EuroQOL (EQ-5D) health states in an adult US sample.","volume":"13","author":"Johnson","year":"1998","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"noi210061r36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jalz.2012.06.008","article-title":"Application of Resource Utilization in Dementia (RUD) instrument in a global setting.","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"24","key":"noi210061r37","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Sample size calculations for ordered categorical data.","volume":"12","author":"Whitehead","year":"1993","journal-title":"Stat Med"},{"issue":"12","key":"noi210061r38","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1001\/archneur.61.12.1852","article-title":"Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial.","volume":"61","author":"Seltzer","year":"2004","journal-title":"Arch Neurol"},{"key":"noi210061r39","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/421385","article-title":"Apathy in Alzheimer\u2019s disease: any effective treatment?","volume":"2014","author":"Rea","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"noi210061r40","doi-asserted-by":"publisher","first-page":"796","DOI":"10.4088\/JCP.10m06708","article-title":"A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer\u2019s disease.","volume":"73","author":"Frakey","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"noi210061r41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/00131746-200405000-00010","article-title":"SSRI-induced apathy syndrome: a clinical review.","volume":"10","author":"Barnhart","year":"2004","journal-title":"J Psychiatr Pract"},{"issue":"33","key":"noi210061r42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021497","article-title":"Selective serotonin reuptake inhibitors-associated apathy syndrome: a cross sectional study.","volume":"99","author":"Padala","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"noi210061r7","author":"Smyth","year":"1997"},{"key":"noi210061r27","volume-title":"Hopkins Verbal Learning Test-Revised Professional Manual.","author":"Brandt","year":"2001"},{"key":"noi210061r28","volume-title":"Wechsler Adult Intelligence Scale: Revised Manual.","author":"Wechsler","year":"1981"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2784538\/jamaneurology_mintzer_2021_oi_210061_1636576245.6009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T16:02:06Z","timestamp":1636646526000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2784538"}},"subtitle":["The ADMET 2 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.3356","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}